These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 29197072

  • 1. Induction of mast cell accumulation by chymase via an enzymatic activity- and intercellular adhesion molecule-1-dependent mechanism.
    Zhang H, Wang J, Wang L, Zhan M, Li S, Fang Z, Xu C, Zheng Y, He S.
    Br J Pharmacol; 2018 Feb; 175(4):678-692. PubMed ID: 29197072
    [Abstract] [Full Text] [Related]

  • 2. Induction of Mast Cell Accumulation by Tryptase via a Protease Activated Receptor-2 and ICAM-1 Dependent Mechanism.
    Liu X, Wang J, Zhang H, Zhan M, Chen H, Fang Z, Xu C, Chen H, He S.
    Mediators Inflamm; 2016 Feb; 2016():6431574. PubMed ID: 27378825
    [Abstract] [Full Text] [Related]

  • 3. Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo.
    He S, Walls AF.
    Br J Pharmacol; 1998 Dec; 125(7):1491-500. PubMed ID: 9884078
    [Abstract] [Full Text] [Related]

  • 4. Signalling mechanisms regulating the activation of human eosinophils by mast-cell-derived chymase: implications for mast cell-eosinophil interaction in allergic inflammation.
    Wong CK, Ng SS, Lun SW, Cao J, Lam CW.
    Immunology; 2009 Apr; 126(4):579-87. PubMed ID: 18771439
    [Abstract] [Full Text] [Related]

  • 5. Induction of mast cell accumulation, histamine release and skin edema by N49 phospholipase A2.
    Wei JF, Wei XL, Mo YZ, He SH.
    BMC Immunol; 2009 Apr 28; 10():21. PubMed ID: 19400930
    [Abstract] [Full Text] [Related]

  • 6. Upregulated expression of substance P (SP) and NK1R in eczema and SP-induced mast cell accumulation.
    Zhan M, Zheng W, Jiang Q, Zhao Z, Wang Z, Wang J, Zhang H, He S.
    Cell Biol Toxicol; 2017 Aug 28; 33(4):389-405. PubMed ID: 28154998
    [Abstract] [Full Text] [Related]

  • 7. Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties.
    Nguyen SD, Maaninka K, Lappalainen J, Nurmi K, Metso J, Öörni K, Navab M, Fogelman AM, Jauhiainen M, Lee-Rueckert M, Kovanen PT.
    Arterioscler Thromb Vasc Biol; 2016 Feb 28; 36(2):274-84. PubMed ID: 26681753
    [Abstract] [Full Text] [Related]

  • 8. Proteome analysis of mast cell releasates reveals a role for chymase in the regulation of coagulation factor XIIIA levels via proteolytic degradation.
    Shubin NJ, Glukhova VA, Clauson M, Truong P, Abrink M, Pejler G, White NJ, Deutsch GH, Reeves SR, Vaisar T, James RG, Piliponsky AM.
    J Allergy Clin Immunol; 2017 Jan 28; 139(1):323-334. PubMed ID: 27302551
    [Abstract] [Full Text] [Related]

  • 9. Mast cell chymase is present in uterine cervical carcinoma and it detaches viable and growing cervical squamous carcinoma cells from substratum in vitro.
    Diaconu NC, Rummukainen J, Naukkarinen A, Mättö M, Harvima RJ, Pelkonen J, Harvima IT.
    Arch Dermatol Res; 2011 Sep 28; 303(7):499-512. PubMed ID: 21274549
    [Abstract] [Full Text] [Related]

  • 10. [Correlations between chymase activity, levels of tryptase, and eotaxin in the sputum of patients with chronic obstructive pulmonary disease and their clinical implications].
    Zhang XJ, He SH, Xie H, Wei JF, Liu CT.
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Oct 28; 27(10):649-53. PubMed ID: 16200864
    [Abstract] [Full Text] [Related]

  • 11. Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation.
    Roy A, Ganesh G, Sippola H, Bolin S, Sawesi O, Dagälv A, Schlenner SM, Feyerabend T, Rodewald HR, Kjellén L, Hellman L, Åbrink M.
    J Biol Chem; 2014 Jan 03; 289(1):237-50. PubMed ID: 24257755
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of tryptase and chymase induced nucleated cell infiltration by proteinase inhibitors.
    He SH, Chen HQ, Zheng J.
    Acta Pharmacol Sin; 2004 Dec 03; 25(12):1677-84. PubMed ID: 15569415
    [Abstract] [Full Text] [Related]

  • 13. Mast cell chymase regulates dermal mast cell number in mice.
    Tomimori Y, Muto T, Fukami H, Saito K, Horikawa C, Tsuruoka N, Yamashiro K, Saito M, Sugiura N, Sumida M, Kakutani S, Fukuda Y.
    Biochem Biophys Res Commun; 2002 Feb 08; 290(5):1478-82. PubMed ID: 11820788
    [Abstract] [Full Text] [Related]

  • 14. Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis.
    Terakawa M, Fujieda Y, Tomimori Y, Muto T, Tanaka T, Maruoka H, Nagahira K, Ogata A, Nakatsuka T, Fukuda Y.
    Eur J Pharmacol; 2008 Dec 28; 601(1-3):186-91. PubMed ID: 18996112
    [Abstract] [Full Text] [Related]

  • 15. Extended cleavage specificity of the mast cell chymase from the crab-eating macaque (Macaca fascicularis): an interesting animal model for the analysis of the function of the human mast cell chymase.
    Thorpe M, Yu J, Boinapally V, Ahooghalandari P, Kervinen J, Garavilla Ld, Hellman L.
    Int Immunol; 2012 Dec 28; 24(12):771-82. PubMed ID: 22949566
    [Abstract] [Full Text] [Related]

  • 16. Mast cell chymase modulates IL-33 levels and controls allergic sensitization in dust-mite induced airway inflammation.
    Waern I, Lundequist A, Pejler G, Wernersson S.
    Mucosal Immunol; 2013 Sep 28; 6(5):911-20. PubMed ID: 23235745
    [Abstract] [Full Text] [Related]

  • 17. Induction of mast-cell accumulation by promutoxin, an Arg-49 phospholipase A2.
    Wei JF, Wei XL, Mo YZ, Yang H, He S.
    Biomed Res Int; 2013 Sep 28; 2013():206061. PubMed ID: 23509689
    [Abstract] [Full Text] [Related]

  • 18. Evidence for in vivo degradation of C3a anaphylatoxin by mast cell chymase. I. Nonspecific activation of rat peritoneal mast cells by C3ades Arg.
    Kajita T, Hugli TE.
    Am J Pathol; 1991 Jun 28; 138(6):1359-69. PubMed ID: 2053593
    [Abstract] [Full Text] [Related]

  • 19. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma.
    Diaconu NC, Kaminska R, Naukkarinen A, Harvima RJ, Harvima IT.
    J Eur Acad Dermatol Venereol; 2007 Aug 28; 21(7):908-15. PubMed ID: 17658999
    [Abstract] [Full Text] [Related]

  • 20. Chymase inhibitor improves dermatitis in NC/Nga mice.
    Watanabe N, Tomimori Y, Saito K, Miura K, Wada A, Tsudzuki M, Fukuda Y.
    Int Arch Allergy Immunol; 2002 Jul 28; 128(3):229-34. PubMed ID: 12119505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.